Back to JANE STREET GROUP, LLC JANE STREET GROUP, LLC

ADAPYADAPY
16 quarters

Position history for JANE STREET GROUP, LLCJANE STREET GROUP, LLC's holdings in ADAPTIMMUNE THERAPEUTICS PLC

No. Jane Street Group exited its ADAPY (Adaptimmune Therapeutics) position in Q4 2025. Its Q3 2025 13F listed 2,805,345 shares worth $364,694. Jane Street Group first reported ADAPY in Q4 2020 and held it in 11 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$153,000

Total Shares Change

-28,373

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%$0.03
0
2025-Q3
New
2.8M
-
$364,6940.0%$0.14
33
2025-Q1
Exited
0
-100.0%
$00.0%$0.21
0
2024-Q4
Increased
326,937
+87.7%
$176,1210.0%$0.55
24
2024-Q3
Increased
174,157
+130.4%
$165,5190.0%$0.98
25
2024-Q2
New
75,576
-
$73,6790.0%$0.98
32
2024-Q1
Exited
0
-100.0%
$00.0%$1.58
0
2023-Q4
New
97,580
-
$77,3810.0%$0.79
33
2022-Q3
Exited
0
-100.0%
$00.0%$1.06
0
2022-Q2
New
44,086
-
$75,0000.0%$1.71
33
2022-Q1
Exited
0
-100.0%
$00.0%$2.06
0
2021-Q4
Decreased
20,249
-51.7%
$76,0000.0%$3.87
0
2021-Q3
Increased
41,930
+36.6%
$216,0000.0%$5.20
30
2021-Q2
Increased
30,696
+67.6%
$130,0000.0%$4.39
33
2021-Q1
Decreased
18,315
-35.5%
$97,0000.0%$5.05
0
2020-Q4
New
28,373
-
$153,0000.0%$5.41
31

Other major holders of ADAPY: RA CAPITAL MANAGEMENT, L.P., Avoro Capital Advisors LLC, Capital World Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used